Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

415.21 -2.63 (-0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
69 70 Next >
News headline image
Why Is WideOpenWest (WOW) Stock Up 30% Today? ↗
WideOpenWest stock is up on Friday after the technology company received a $4.80 per share in cash takeover offer for WOW shares. 
Via InvestorPlace
News headline image
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up ↗
To gain an edge, this is what you need to know today. 
Via Benzinga
News headline image
AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company? ↗
Amgen (AMGN) stock is soaring after the company's CEO said he was "very encouraged" by interim data for Amgen's new weight-loss drug. 
Via InvestorPlace
News headline image
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Amgen's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
News headline image
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens ↗
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report. 
Via Benzinga
News headline image
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate ↗
MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1. 
Via Benzinga
News headline image
How Is The Market Feeling About Amgen? ↗
 
Via Benzinga
News headline image
Apple, Coinbase, Block, Amgen, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66 
Via Benzinga
Topics Stocks
News headline image
AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024 ↗
AMGN stock results show that Amgen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment ↗
Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses... 
Via Benzinga
News headline image
Amgen Beats First-Quarter Expectations, But Shares Slide As Investors Watch Obesity Space ↗
The company confirmed it's still running a midstage study of its obesity drug, MariTide. 
Via Investor's Business Daily
News headline image
Ticking Time Bombs: 3 Dow Stocks to Dump While You Still Can ↗
Uncover the vulnerabilities of these Dow stocks to sell, with potential declines due to cash flow issues, pricing pressures and flat sales. 
Via InvestorPlace
Topics Stocks
News headline image
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday? ↗
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains. 
Via Benzinga
Topics Economy
News headline image
Moody’s, Booking, DraftKings, Amgen Stocks In Focus Ahead Of Earnings ↗
American stocks were mixed on Wednesday as the earnings season continued and as investors waited for the latest Federal Reserve decision. The Dow Jones rose by over 65 points while the S&P 500 and... 
Via Talk Markets
Topics Economy Stocks
News headline image
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market ↗
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday. 
Via Benzinga
Topics Stocks
News headline image
What's Going On With CytomX Stock? ↗
CytomX Therapeutics shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8, after the close of... 
Via Benzinga
News headline image
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab ↗
Sandoz resolves patent litigation with Amgen, paving the way for the launch of denosumab biosimilars Jubbonti and Wyost. 
Via Benzinga
Topics Intellectual Property
News headline image
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday? ↗
Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus... 
Via Benzinga
News headline image
Better Buy: Pfizer vs. Viking Therapeutics ↗
These two pharma stocks have followed distinct paths of late. Which is the better investment? 
Via The Motley Fool
News headline image
1 No-Brainer Vanguard Fund to Buy Right Now ↗
This Vanguard growth fund is home to some of the world's most innovative companies. 
Via The Motley Fool
News headline image
The Dividend Goldmine: 3 Shining Stocks With Growing Payouts ↗
Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns. 
Via InvestorPlace
News headline image
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick ↗
Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300... 
Via Benzinga
News headline image
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring ↗
When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue. 
Via InvestorPlace
News headline image
Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble ↗
Though stocks that make the Dow 30 are often seen as solid investments, investors should consider these three blue chip stocks to sell. 
Via InvestorPlace
Topics Stocks
News headline image
Can This High-Yield Dividend Stock Keep Beating the S&P 500? ↗
Amgen's shares have come under pressure this year, making it a compelling bargain buy. 
Via The Motley Fool
Topics Stocks
News headline image
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever ↗
Not every business in operation today is built to thrive -- or even last -- indefinitely. These are. 
Via The Motley Fool
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.